HEADER TRANSFERASE/INHIBITOR 16-JUN-21 7N91 TITLE P70 S6K1 IN COMPLEX WITH MSC2317067A-1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: RIBOSOMAL PROTEIN S6 KINASE BETA-1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN (81-421) DIGEST; COMPND 5 SYNONYM: S6K-BETA-1,S6K1,70 KDA RIBOSOMAL PROTEIN S6 KINASE 1, COMPND 6 P70S6K1,P70-S6K 1,RIBOSOMAL PROTEIN S6 KINASE I,SERINE/THREONINE- COMPND 7 PROTEIN KINASE 14A,P70 RIBOSOMAL S6 KINASE ALPHA,P70 S6 KINASE ALPHA, COMPND 8 P70 S6K-ALPHA,P70 S6KA; COMPND 9 EC: 2.7.11.1; COMPND 10 ENGINEERED: YES; COMPND 11 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RPS6KB1, STK14A; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE DOMAIN, INHIBITOR, TRANSFERASE, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR I.MOCHALKIN REVDAT 3 18-OCT-23 7N91 1 REMARK REVDAT 2 23-NOV-22 7N91 1 JRNL REVDAT 1 06-JUL-22 7N91 0 JRNL AUTH L.DESELM,B.HUCK,R.LAN,C.NEAGU,J.POTNICK,Y.XIAO,X.CHEN, JRNL AUTH 2 R.JONES,T.E.RICHARDSON,B.H.HEASLEY,T.HAXELL,J.MOORE,H.TIAN, JRNL AUTH 3 K.GEORGI,F.ROHDICH,A.SUTTON,T.JOHNSON,I.MOCHALKIN,J.JACKSON, JRNL AUTH 4 J.LIN,L.CROWLEY,A.MACHL,A.CLARK,E.WILKER,B.SHERER, JRNL AUTH 5 A.GOUTOPOULOS JRNL TITL IDENTIFICATION OF CLINICAL CANDIDATE M2698, A DUAL P70S6K JRNL TITL 2 AND AKT INHIBITOR, FOR TREATMENT OF PAM PATHWAY-ALTERED JRNL TITL 3 CANCERS. JRNL REF J.MED.CHEM. V. 64 14603 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 34596404 JRNL DOI 10.1021/ACS.JMEDCHEM.1C01087 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.52 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.1 REMARK 3 NUMBER OF REFLECTIONS : 13883 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.272 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4974 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 50 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.72 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7N91 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-JUN-21. REMARK 100 THE DEPOSITION ID IS D_1000257605. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-MAR-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13883 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 46.520 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 200 DATA REDUNDANCY : 5.870 REMARK 200 R MERGE (I) : 0.14800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.17 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.8 REMARK 200 DATA REDUNDANCY IN SHELL : 5.49 REMARK 200 R MERGE FOR SHELL (I) : 0.52200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.860 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3A60 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.81 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M BIS-TRIS PH 5.5, 0.1M LI2SO4, 26 REMARK 280 -28% PEG3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.65000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.01500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.27500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 75.01500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.65000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.27500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 82 REMARK 465 PRO A 83 REMARK 465 GLU A 84 REMARK 465 THR A 112 REMARK 465 GLY A 113 REMARK 465 ALA A 114 REMARK 465 CYS A 240 REMARK 465 LYS A 241 REMARK 465 GLU A 242 REMARK 465 SER A 243 REMARK 465 ILE A 244 REMARK 465 HIS A 245 REMARK 465 ASP A 246 REMARK 465 GLY A 247 REMARK 465 THR A 248 REMARK 465 VAL A 249 REMARK 465 THR A 250 REMARK 465 HIS A 251 REMARK 465 THR A 252 REMARK 465 PHE A 253 REMARK 465 CYS A 254 REMARK 465 ASP A 396 REMARK 465 ASP A 397 REMARK 465 SER A 398 REMARK 465 THR A 399 REMARK 465 LEU A 400 REMARK 465 SER A 401 REMARK 465 GLU A 402 REMARK 465 SER A 403 REMARK 465 ALA A 404 REMARK 465 LEU A 419 REMARK 465 GLU A 420 REMARK 465 SER A 421 REMARK 465 GLY B 82 REMARK 465 PRO B 83 REMARK 465 GLU B 84 REMARK 465 LYS B 241 REMARK 465 GLU B 242 REMARK 465 SER B 243 REMARK 465 ILE B 244 REMARK 465 HIS B 245 REMARK 465 ASP B 246 REMARK 465 GLY B 247 REMARK 465 THR B 248 REMARK 465 VAL B 249 REMARK 465 THR B 250 REMARK 465 HIS B 251 REMARK 465 THR B 252 REMARK 465 PHE B 253 REMARK 465 CYS B 254 REMARK 465 GLY B 255 REMARK 465 ASP B 396 REMARK 465 ASP B 397 REMARK 465 SER B 398 REMARK 465 THR B 399 REMARK 465 LEU B 400 REMARK 465 SER B 401 REMARK 465 LEU B 419 REMARK 465 GLU B 420 REMARK 465 SER B 421 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 159 -75.16 -92.08 REMARK 500 THR A 164 -163.87 -119.77 REMARK 500 LEU A 175 78.45 -100.79 REMARK 500 SER A 176 6.96 -69.01 REMARK 500 ILE A 189 129.84 -32.37 REMARK 500 ARG A 217 -55.81 69.01 REMARK 500 ASN A 227 -170.51 -67.61 REMARK 500 THR A 317 174.24 -57.92 REMARK 500 ASP A 342 -128.23 55.20 REMARK 500 SEP A 394 137.51 -37.46 REMARK 500 PHE A 408 33.56 -81.72 REMARK 500 GLU A 412 136.90 -33.30 REMARK 500 THR B 116 139.70 -30.29 REMARK 500 ARG B 217 -54.81 59.67 REMARK 500 PRO B 221 0.95 -59.64 REMARK 500 ASN B 227 -168.21 -78.27 REMARK 500 ARG B 267 13.48 53.63 REMARK 500 SER B 268 48.27 -97.96 REMARK 500 HIS B 270 143.31 177.45 REMARK 500 ASN B 271 -157.38 -119.22 REMARK 500 ASN B 297 -170.83 -172.59 REMARK 500 LYS B 307 -74.90 -121.83 REMARK 500 LEU B 328 50.86 -91.60 REMARK 500 ASP B 342 -129.32 50.44 REMARK 500 REMARK 500 REMARK: NULL DBREF 7N91 A 82 421 UNP P23443 KS6B1_HUMAN 82 421 DBREF 7N91 B 82 421 UNP P23443 KS6B1_HUMAN 82 421 SEQADV 7N91 GLU A 412 UNP P23443 THR 412 ENGINEERED MUTATION SEQADV 7N91 GLU B 412 UNP P23443 THR 412 ENGINEERED MUTATION SEQRES 1 A 340 GLY PRO GLU LYS ILE ARG PRO GLU CYS PHE GLU LEU LEU SEQRES 2 A 340 ARG VAL LEU GLY LYS GLY GLY TYR GLY LYS VAL PHE GLN SEQRES 3 A 340 VAL ARG LYS VAL THR GLY ALA ASN THR GLY LYS ILE PHE SEQRES 4 A 340 ALA MET LYS VAL LEU LYS LYS ALA MET ILE VAL ARG ASN SEQRES 5 A 340 ALA LYS ASP THR ALA HIS THR LYS ALA GLU ARG ASN ILE SEQRES 6 A 340 LEU GLU GLU VAL LYS HIS PRO PHE ILE VAL ASP LEU ILE SEQRES 7 A 340 TYR ALA PHE GLN THR GLY GLY LYS LEU TYR LEU ILE LEU SEQRES 8 A 340 GLU TYR LEU SER GLY GLY GLU LEU PHE MET GLN LEU GLU SEQRES 9 A 340 ARG GLU GLY ILE PHE MET GLU ASP THR ALA CYS PHE TYR SEQRES 10 A 340 LEU ALA GLU ILE SER MET ALA LEU GLY HIS LEU HIS GLN SEQRES 11 A 340 LYS GLY ILE ILE TYR ARG ASP LEU LYS PRO GLU ASN ILE SEQRES 12 A 340 MET LEU ASN HIS GLN GLY HIS VAL LYS LEU THR ASP PHE SEQRES 13 A 340 GLY LEU CYS LYS GLU SER ILE HIS ASP GLY THR VAL THR SEQRES 14 A 340 HIS THR PHE CYS GLY THR ILE GLU TYR MET ALA PRO GLU SEQRES 15 A 340 ILE LEU MET ARG SER GLY HIS ASN ARG ALA VAL ASP TRP SEQRES 16 A 340 TRP SER LEU GLY ALA LEU MET TYR ASP MET LEU THR GLY SEQRES 17 A 340 ALA PRO PRO PHE THR GLY GLU ASN ARG LYS LYS THR ILE SEQRES 18 A 340 ASP LYS ILE LEU LYS CYS LYS LEU ASN LEU PRO PRO TYR SEQRES 19 A 340 LEU THR GLN GLU ALA ARG ASP LEU LEU LYS LYS LEU LEU SEQRES 20 A 340 LYS ARG ASN ALA ALA SER ARG LEU GLY ALA GLY PRO GLY SEQRES 21 A 340 ASP ALA GLY GLU VAL GLN ALA HIS PRO PHE PHE ARG HIS SEQRES 22 A 340 ILE ASN TRP GLU GLU LEU LEU ALA ARG LYS VAL GLU PRO SEQRES 23 A 340 PRO PHE LYS PRO LEU LEU GLN SER GLU GLU ASP VAL SER SEQRES 24 A 340 GLN PHE ASP SER LYS PHE THR ARG GLN TPO PRO VAL ASP SEQRES 25 A 340 SEP PRO ASP ASP SER THR LEU SER GLU SER ALA ASN GLN SEQRES 26 A 340 VAL PHE LEU GLY PHE GLU TYR VAL ALA PRO SER VAL LEU SEQRES 27 A 340 GLU SER SEQRES 1 B 340 GLY PRO GLU LYS ILE ARG PRO GLU CYS PHE GLU LEU LEU SEQRES 2 B 340 ARG VAL LEU GLY LYS GLY GLY TYR GLY LYS VAL PHE GLN SEQRES 3 B 340 VAL ARG LYS VAL THR GLY ALA ASN THR GLY LYS ILE PHE SEQRES 4 B 340 ALA MET LYS VAL LEU LYS LYS ALA MET ILE VAL ARG ASN SEQRES 5 B 340 ALA LYS ASP THR ALA HIS THR LYS ALA GLU ARG ASN ILE SEQRES 6 B 340 LEU GLU GLU VAL LYS HIS PRO PHE ILE VAL ASP LEU ILE SEQRES 7 B 340 TYR ALA PHE GLN THR GLY GLY LYS LEU TYR LEU ILE LEU SEQRES 8 B 340 GLU TYR LEU SER GLY GLY GLU LEU PHE MET GLN LEU GLU SEQRES 9 B 340 ARG GLU GLY ILE PHE MET GLU ASP THR ALA CYS PHE TYR SEQRES 10 B 340 LEU ALA GLU ILE SER MET ALA LEU GLY HIS LEU HIS GLN SEQRES 11 B 340 LYS GLY ILE ILE TYR ARG ASP LEU LYS PRO GLU ASN ILE SEQRES 12 B 340 MET LEU ASN HIS GLN GLY HIS VAL LYS LEU THR ASP PHE SEQRES 13 B 340 GLY LEU CYS LYS GLU SER ILE HIS ASP GLY THR VAL THR SEQRES 14 B 340 HIS THR PHE CYS GLY THR ILE GLU TYR MET ALA PRO GLU SEQRES 15 B 340 ILE LEU MET ARG SER GLY HIS ASN ARG ALA VAL ASP TRP SEQRES 16 B 340 TRP SER LEU GLY ALA LEU MET TYR ASP MET LEU THR GLY SEQRES 17 B 340 ALA PRO PRO PHE THR GLY GLU ASN ARG LYS LYS THR ILE SEQRES 18 B 340 ASP LYS ILE LEU LYS CYS LYS LEU ASN LEU PRO PRO TYR SEQRES 19 B 340 LEU THR GLN GLU ALA ARG ASP LEU LEU LYS LYS LEU LEU SEQRES 20 B 340 LYS ARG ASN ALA ALA SER ARG LEU GLY ALA GLY PRO GLY SEQRES 21 B 340 ASP ALA GLY GLU VAL GLN ALA HIS PRO PHE PHE ARG HIS SEQRES 22 B 340 ILE ASN TRP GLU GLU LEU LEU ALA ARG LYS VAL GLU PRO SEQRES 23 B 340 PRO PHE LYS PRO LEU LEU GLN SER GLU GLU ASP VAL SER SEQRES 24 B 340 GLN PHE ASP SER LYS PHE THR ARG GLN TPO PRO VAL ASP SEQRES 25 B 340 SEP PRO ASP ASP SER THR LEU SER GLU SER ALA ASN GLN SEQRES 26 B 340 VAL PHE LEU GLY PHE GLU TYR VAL ALA PRO SER VAL LEU SEQRES 27 B 340 GLU SER MODRES 7N91 TPO A 390 THR MODIFIED RESIDUE MODRES 7N91 SEP A 394 SER MODIFIED RESIDUE MODRES 7N91 TPO B 390 THR MODIFIED RESIDUE MODRES 7N91 SEP B 394 SER MODIFIED RESIDUE HET TPO A 390 11 HET SEP A 394 10 HET TPO B 390 11 HET SEP B 394 10 HET 1RJ A 501 25 HET 1RJ B 501 25 HETNAM TPO PHOSPHOTHREONINE HETNAM SEP PHOSPHOSERINE HETNAM 1RJ 4-{[(1S)-1-(3-FLUOROPHENYL)-2-(METHYLAMINO) HETNAM 2 1RJ ETHYL]AMINO}QUINAZOLINE-8-CARBOXAMIDE HETSYN TPO PHOSPHONOTHREONINE HETSYN SEP PHOSPHONOSERINE FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 1 SEP 2(C3 H8 N O6 P) FORMUL 3 1RJ 2(C18 H18 F N5 O) HELIX 1 AA1 ARG A 87 GLU A 89 5 3 HELIX 2 AA2 LYS A 127 VAL A 131 1 5 HELIX 3 AA3 ASN A 133 VAL A 150 1 18 HELIX 4 AA4 GLU A 179 GLY A 188 1 10 HELIX 5 AA5 MET A 191 LYS A 212 1 22 HELIX 6 AA6 LYS A 220 GLU A 222 5 3 HELIX 7 AA7 ALA A 261 MET A 266 1 6 HELIX 8 AA8 ARG A 272 GLY A 289 1 18 HELIX 9 AA9 ASN A 297 CYS A 308 1 12 HELIX 10 AB1 THR A 317 LEU A 328 1 12 HELIX 11 AB2 ASP A 342 HIS A 349 1 8 HELIX 12 AB3 PRO A 350 ARG A 353 5 4 HELIX 13 AB4 ASN A 356 ALA A 362 1 7 HELIX 14 AB5 ASP A 383 ARG A 388 1 6 HELIX 15 AB6 ARG B 87 GLU B 89 5 3 HELIX 16 AB7 LYS B 127 ARG B 132 1 6 HELIX 17 AB8 ASN B 133 VAL B 150 1 18 HELIX 18 AB9 LEU B 180 GLY B 188 1 9 HELIX 19 AC1 MET B 191 LYS B 212 1 22 HELIX 20 AC2 ALA B 261 MET B 266 1 6 HELIX 21 AC3 ARG B 272 GLY B 289 1 18 HELIX 22 AC4 ASN B 297 LYS B 307 1 11 HELIX 23 AC5 THR B 317 LEU B 328 1 12 HELIX 24 AC6 ASN B 331 ARG B 335 5 5 HELIX 25 AC7 ASP B 342 ALA B 348 1 7 HELIX 26 AC8 HIS B 349 ARG B 353 5 5 HELIX 27 AC9 ASN B 356 ALA B 362 1 7 HELIX 28 AD1 ASP B 383 ARG B 388 1 6 SHEET 1 AA1 6 PHE A 91 LYS A 99 0 SHEET 2 AA1 6 GLY A 103 LYS A 110 -1 O GLN A 107 N LEU A 94 SHEET 3 AA1 6 ILE A 119 LYS A 126 -1 O MET A 122 N PHE A 106 SHEET 4 AA1 6 LYS A 167 GLU A 173 -1 O LEU A 172 N ALA A 121 SHEET 5 AA1 6 LEU A 158 GLN A 163 -1 N TYR A 160 O ILE A 171 SHEET 6 AA1 6 TYR A 413 VAL A 414 -1 O TYR A 413 N ALA A 161 SHEET 1 AA2 2 ILE A 224 LEU A 226 0 SHEET 2 AA2 2 VAL A 232 LEU A 234 -1 O LYS A 233 N MET A 225 SHEET 1 AA3 6 PHE B 91 LYS B 99 0 SHEET 2 AA3 6 GLY B 103 LYS B 110 -1 O VAL B 105 N GLY B 98 SHEET 3 AA3 6 ILE B 119 LYS B 126 -1 O PHE B 120 N VAL B 108 SHEET 4 AA3 6 LYS B 167 GLU B 173 -1 O LEU B 170 N LYS B 123 SHEET 5 AA3 6 LEU B 158 THR B 164 -1 N TYR B 160 O ILE B 171 SHEET 6 AA3 6 TYR B 413 VAL B 414 -1 O TYR B 413 N ALA B 161 SHEET 1 AA4 3 GLY B 178 GLU B 179 0 SHEET 2 AA4 3 ILE B 224 LEU B 226 -1 O LEU B 226 N GLY B 178 SHEET 3 AA4 3 VAL B 232 LEU B 234 -1 O LYS B 233 N MET B 225 LINK C GLN A 389 N TPO A 390 1555 1555 1.33 LINK C TPO A 390 N PRO A 391 1555 1555 1.34 LINK C ASP A 393 N SEP A 394 1555 1555 1.33 LINK C SEP A 394 N PRO A 395 1555 1555 1.35 LINK C GLN B 389 N TPO B 390 1555 1555 1.33 LINK C TPO B 390 N PRO B 391 1555 1555 1.34 LINK C ASP B 393 N SEP B 394 1555 1555 1.33 LINK C SEP B 394 N PRO B 395 1555 1555 1.34 CRYST1 59.300 74.550 150.030 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016863 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013414 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006665 0.00000